Wednesday 14 October 2026
Export CI’s income statement to Excel — free account
Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
282.53
0.81
−0.29%
Follow CI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 9 |
+8 more TTM periods Free account |
| 15.40% | 15.18% | 14.33% | 14.58% | ||
| 4.16% | 4.14% | 3.80% | 3.90% | ||
ROIC |
9.09% | 9.04% | 8.76% | 8.06% | |
Return on Tangible Assets |
(59.71%) | (56.23%) | (49.05%) | (56.59%) | |
Average Days of Receivables |
44.96 | 40.30 | 43.64 | 48.90 | |
Free Cash Flow per Share |
34.65 | 29.15 | 31.45 | 27.97 | |
Free Cash Flow |
9,113.00 | 7,660.00 | 8,389.00 | 7,437.00 | |
Capital Expenditures |
(1,164.00) | (1,152.00) | (1,212.00) | (1,227.00) | |
| Other line items | |||||
Cash ROIC |
11.24% | 9.53% | 10.36% | 9.06% | |
Accounts Receivable Turnover |
8.04 | 8.97 | 8.94 | 7.85 | |
Accounts Payable Turnover |
0.85 | 0.87 | 0.87 | 0.94 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
411.99 | 409.42 | 435.59 | 399.15 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.19) | (0.20) | (0.19) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.02% | 5.08% | 5.32% | 5.55% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
7.00 | 6.83 | 6.53 | 6.41 | |
Operating CF/Net income |
1.60 | 1.40 | 1.61 | 1.41 | |
Depreciation/Fixed assets |
0.73 | 0.74 | 0.76 | 0.74 | |
Capex/Depreciation |
(0.43) | (0.42) | (0.44) | (0.45) | |
Revenue per Share |
1,073.75 | 1,057.65 | 1,030.58 | 1,008.14 | |
Operating CF per Share |
39.08 | 33.54 | 35.99 | 32.58 | |
Capex per Share |
(4.43) | (4.38) | (4.54) | (4.61) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates